Published in Cancer Lett on September 10, 2001
Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control (2012) 1.00
Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harbouring the hOGG1-Cys326 polymorphic variant. Nucleic Acids Res (2005) 0.95
Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol (2003) 0.88
The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. PLoS One (2011) 0.88
Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries. World J Gastroenterol (2014) 0.80
Absence of MutY homologue mutation in patients with multiple sporadic adenomatous polyps in Korea. World J Gastroenterol (2006) 0.76
HOGG1 polymorphism in atrophic gastritis and gastric cancer after Helicobacter pylori eradication. World J Gastroenterol (2010) 0.76
Association between the OGG1 Ser326Cys Polymorphism and Cancer Risk: Evidence from 152 Case-Control Studies. J Cancer (2016) 0.75
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci (1999) 4.27
Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet (1986) 3.93
Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet (2001) 3.84
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50
Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem (1995) 3.45
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 2.97
Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem (1996) 2.95
Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4)photoproduct from the same mouse immunized with ultraviolet-irradiated DNA. Photochem Photobiol (1991) 2.84
Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev (1998) 2.82
Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem (1997) 2.73
Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A (1996) 2.68
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet (2000) 2.67
Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aero-digestive tract in Brazil. Am J Epidemiol (1999) 2.49
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A (1994) 2.43
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A (2001) 2.39
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science (1986) 2.33
Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet (2000) 2.30
Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J Neurosci (2001) 2.29
Widespread expression of Huntington's disease gene (IT15) protein product. Neuron (1995) 2.29
Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene (2007) 2.27
Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem (1995) 2.26
Epidemiology of gastric cancer in Japan. Postgrad Med J (2005) 2.24
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci U S A (2001) 2.00
Interaction of huntingtin-associated protein with dynactin P150Glued. J Neurosci (1998) 1.98
Divergent projection of individual corticospinal axons to motoneurons of multiple muscles in the monkey. Neurosci Lett (1981) 1.96
Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene (1998) 1.92
Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol (1999) 1.91
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 1.90
The nucleotide sequence of the cloned nusA gene and its flanking region of Escherichia coli. Nucleic Acids Res (1984) 1.87
A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood (2000) 1.86
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum Mol Genet (1999) 1.86
A new photoreactivating enzyme that specifically repairs ultraviolet light-induced (6-4)photoproducts. Nature (1993) 1.79
Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. Oncogene (2011) 1.78
Initiator tRNAs from archaebacteria show common unique sequence characteristics. Nature (1982) 1.78
[Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity. Biochem Biophys Res Commun (1991) 1.78
Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell (1991) 1.74
Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci U S A (1989) 1.73
Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex. J Biol Chem (1998) 1.72
Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res (1987) 1.70
Biosynthesis of porphyrins and related macrocycles. Part 10. Vitamin B12: biochemical derivation of cobyrinic acid from uroporphyrinogen III. Studies with corresponding ring c methyl heptacarboxylic prophyrinogen, and proof of seven intact methyl transfers. J Chem Soc Perkin 1 (1977) 1.69
Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene (1997) 1.69
Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron (1993) 1.69
A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg (1997) 1.68
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci U S A (2001) 1.67
Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation (1996) 1.66
Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J Virol (1989) 1.66
Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis (2003) 1.64
Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg (2000) 1.64
Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene (1990) 1.63
Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol (1991) 1.60
8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett (1995) 1.60
Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res (1989) 1.58
Catabolite repression of the Bacillus subtilis gnt operon exerted by two catabolite-responsive elements. Mol Microbiol (1997) 1.56
Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res (1994) 1.55
Structure of a modified nucleoside in archaebacterial tRNA which replaces ribosylthymine. 1-Methylpseudouridine. J Biol Chem (1982) 1.51
Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci U S A (2001) 1.49
Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res (1994) 1.47
Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabet Med (2005) 1.46
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther (2001) 1.45
Mutations of the p53 tumour suppressor gene in haematologic neoplasms. Br J Haematol (1992) 1.44
Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res (1992) 1.44
Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res (1991) 1.43
Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene (2006) 1.43
Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study. BJOG (2014) 1.41
Subinsular vascular lesions: an analysis of 119 consecutive autopsied brains. Eur J Neurol (2007) 1.40
Involvement of level I neck lymph nodes in advanced squamous carcinoma of the larynx. Ann Otol Rhinol Laryngol (2001) 1.40
Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions. J Biol Chem (1998) 1.40
Juvenile intraoral pleomorphic adenoma: report of five cases and review of the literature. Int J Oral Maxillofac Surg (2002) 1.38
Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum Mol Genet (1998) 1.38
A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor. Cell (1990) 1.38
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A (2009) 1.37
Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Res (1996) 1.36
The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J Neurosci (1998) 1.33
Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells (1999) 1.33
p53 mutations in human lung tumors. Cancer Res (1992) 1.33
Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J (2001) 1.32
Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer (2001) 1.32
Archaebacterial tRNA contains 1-methylinosine at residue 57 in T psi C-loop. Nucleic Acids Symp Ser (1982) 1.32
alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. Oncogene (1999) 1.31
Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology (2007) 1.29
Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics (1999) 1.29
p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res (1991) 1.29
Attributable causes of cancer in Japan in 2005--systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol (2011) 1.28
Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc Natl Acad Sci U S A (1988) 1.28
Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut (2001) 1.27
Modelling of mortality data from a multi-centre study in Japan by means of Poisson regression with error in variables. Int J Epidemiol (1997) 1.26
Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res (1998) 1.26
Urinary bisphenol A and plasma hormone concentrations in male workers exposed to bisphenol A diglycidyl ether and mixed organic solvents. Occup Environ Med (2002) 1.26
Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer (1998) 1.25
A clinicopathologic study of 196 intraoral minor salivary gland tumours. J Oral Pathol Med (1999) 1.25
Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1. Biochem Biophys Res Commun (1992) 1.24
Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci U S A (2001) 1.24